Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Uncover the best no annual fee rewards card for your needs. Our guide helps you navigate options to enhance your spending benefits.
23,410 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
SoundHound posted revenue gains for the quarter, yet earnings slipped as acquisition-related costs weighed on results...
Pi Network reports rising KYC completion and robust Mainnet migration, as upgrades lay groundwork for smart contracts...
A half-century-old rule for scaling software teams is breaking as AI fueled capital changes how firms grow. Investors...
Roundhill's DRAM ETF, with a 49% Korea weighting, has surged but faces overnight gaps as half its holdings trade when...
A small-cap memory-interface provider, Lumina IP, reports gross margins near 80% in Q1 2026 as AI accelerators push d...
A once-bleeding-edge EV player shows measurable progress: rising revenue, better vehicle margins, smaller losses, and...
Celebrities walk a fine line between humor and harm. When kevin hart says oprah is off-limits, it reveals how powerfu...
Emerging markets are outpacing the S&P 500 in 2026, with EEM posting a double-digit lead year-to-date. The rally cent...
Palantir rode the AI wave to big gains, but recent performance has paused. This guide analyzes whether palantir stock...
Public equity plays are moving to the front line of U.S. industrial policy. Intel’s strong run after government invol...
Palantir tumbles about 7% midday as Palo Alto Networks and CrowdStrike hold steadier, raising questions about governm...